Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

(ANTX) (ANTX) Insider Trading & Ownership

(ANTX) logo

(ANTX) (NYSE:ANTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.79%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$1.76 M
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$9.70 M
Get ANTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling (ANTX) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ANTX Insider Buying and Selling by Quarter

(ANTX) Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2024Robin Shane ReadnourDirectorBuy30,772$1.43$44,003.96  
12/6/2024Robin Shane ReadnourDirectorBuy19,228$1.45$27,880.60  
11/27/2024Joseph S ZakrzewskiDirectorBuy2,000$1.40$2,800.00  
11/20/2024Robin Shane ReadnourDirectorBuy50,000$1.16$58,000.00  
11/18/2024Eric EasomCEOBuy50,000$1.00$50,000.00  
11/18/2024Joseph S ZakrzewskiDirectorBuy20,000$1.00$20,000.00  
8/14/2024Braden Michael LeonardMajor ShareholderBuy1,500,000$1.04$1,560,000.00  
8/9/2024Ra Capital Management, L.P.Major ShareholderSell3,525,094$1.08$3,807,101.52  
1/18/2024Joseph S ZakrzewskiDirectorSell100,000$19.11$1,911,000.00  
1/16/2024Global Health Technol AdjuvantMajor ShareholderSell84,093$19.65$1,652,427.45  
1/16/2024Kabeer AzizDirectorSell100,000$19.65$1,965,000.00  
1/12/2024Robin Shane ReadnourDirectorSell1,425$21.91$31,221.75  
1/10/2024Robin Shane ReadnourDirectorSell3,669$21.93$80,461.17  
1/9/2024Kevin Michael KrauseInsiderSell7,417$20.14$149,378.38  
1/2/2024Eric EasomCEOSell2,777$20.09$55,789.93  
1/2/2024Kevin Michael KrauseInsiderSell2,583$20.12$51,969.96  
(Data available from 1/1/2013 forward)

ANTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at (ANTX) includes Braden Michael Leonard, Eric Easom, Global Health Technol Adjuvant, Joseph S Zakrzewski, Kabeer Aziz, Kevin Michael Krause, Ra Capital Management, L.P., and Robin Shane Readnour. Learn more on insiders at ANTX.

20.79% of (ANTX) stock is owned by insiders. Learn more on ANTX's insider holdings.

The following insiders have purchased ANTX shares in the last 24 months: Braden Michael Leonard ($1,560,000.00), Eric Easom ($103,800.00), Joseph S Zakrzewski ($22,800.00), Ra Capital Management, L.P. ($16,000,002.00), and Robin Shane Readnour ($129,884.56).

Insiders have purchased a total of 3,459,778 ANTX shares in the last 24 months for a total of $17,816,486.56 bought.

The following insiders have sold ANTX shares in the last 24 months: Eric Easom ($55,789.93), Global Health Technol Adjuvant ($3,183,188.78), Joseph S Zakrzewski ($1,911,000.00), Kabeer Aziz ($3,785,326.93), Kevin Michael Krause ($201,348.34), Ra Capital Management, L.P. ($3,807,101.52), and Robin Shane Readnour ($111,682.92).

Insiders have sold a total of 4,033,216 (ANTX) shares in the last 24 months for a total of $13,055,438.42 sold.



This page (NYSE:ANTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners